VEGFA and age-related macular degeneration: The most commonly used and most effective treatment for exudative AMD is anti-VEGF therapy (Wykoff et al., 2013), however, approximately 19.7%–36.6% of patients are resistant to this typically used treatment (Heier et al., 2012).